Investment bank Cantor Fitzgerald lowers Strategy's target price by 59% to $229, but maintains "Overweight" rating
According to ChainCatcher, analysts at investment bank Cantor Fitzgerald have set a 12-month target price of $229 for Strategy stock, about 59% lower than the previous expectation of $560. However, Cantor Fitzgerald has reiterated its "Overweight" rating and remains optimistic in the long term.
The analysts now expect that over the next year, Strategy will raise $7.8 billion from the capital markets, instead of the previously expected $22.5 billion.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
PRECIOUS-Gold lacklustre as higher-for-longer rate outlook weighs on sentiment

Novo Nordisk is open to upgrading its New York listing status.

Novo Nordisk considers upgrading its New York listing to boost its U.S. profile
